References
- MartinGSManninoDMEatonSMossMThe epidemiology of sepsis in the United States from 1979 through 2000N Engl J Med20033481546155412700374
- WisplinghoffHSeiffertHWenzelRPEdmondMBCurrent trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United StatesClin Infect Dis2003361103111012715303
- TrickWEFridkinSKEdwardsJRHajjehRAGaynesRPSecular trend of hospital-acquired candidemia among intensive care unit patients in the United StatesClin Infect Dis20023562763012173140
- MarrKACarterRABoeckhMMartinPCoreyLInvasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factorsBlood20021004358436612393425
- ZilberbergMDShorrAFFungal infections in the ICUInfect Dis Clin North Am20092362564219665087
- PemánJLuquePNietoMPozoJCSoléAZaragozaRUpdate on invasive mycoses by flamentous fungi in critically ill patientsEnferm Infecc Microbiol Clin2011293641 Spanish21458718
- PanackalAAMarrKAScedosporium/Pseudoallescheria infectionsSemin Respir Crit Care Med20042517118116088460
- BulpaPDiveASibilleYInvasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseaseEur Respir J20073078280017906086
- AderFNseirSLe BerreRInvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogenClin Microbiol Infect20051142742915882191
- AderFBienvenuALRammaertBNseirSManagement of invasive aspergillosis in patients with COPD: rational use of voriconazoleInt J Chron Obstruct Pulmon Dis2009427929719684861
- CamusetJLavoléAWislezMBronchopulmonary aspergillosis infections in the non-immunocompromised patientRev Pneumol Clin200763155166 French17675939
- GuineaJTorres-NarbonaMGijónPPulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcomeClin Microbiol Infect20101687087719906275
- MuquimADialSMenziesDInvasive aspergillosis in patients with chronic obstructive pulmonary diseaseCan Respir J20051219920416003456
- De PauwBWalshTJDonnellyJPRevised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClin Infect Dis2008461813182118462102
- SegalBHWalshTJCurrent approaches to diagnosis and treatment of invasive aspergillosisAm J Respir Crit Care Med200617370771716387806
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis1987403733833558716
- WalshTJAnaissieEJDenningDWTreatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of AmericaClin Infect Dis20084632736018177225
- TomblynMChillerTEinseleHGuidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspectiveBiol Blood Marrow Transplant2009151143123819747629
- QuiePGSolbergCOInfections in the immunocompromised hostArmstrongDACohenJInfectious DiseasesLondon, UKHarcourt Publishers Ltd2000
- DutkiewiczRHageCAAspergillus infections in the critically illProc Am Thorac Soc2010720420920463249
- MeerssemanWVandercasteeleSJWilmerAVerbekenEPeetermansWEVan WijngaerdenEInvasive aspergillosis in critically ill patients without malignancyAm J Respir Crit Care Med200417062162515229094
- TrofRJBeishuizenADebets-OssenkoppYJGirbesARGroeneveldABManagement of invasive pulmonary aspergillosis in non-neutropenic critically ill patientsIntensive Care Med2007331694170317646966
- VazquezJATovar-TorresMHingweAInvasive aspergillosis: a changing epidemiology in the non-traditional host: risk factors and outcomeAbstract M-1060 presented at the 50th Annual Meeting of the Interscience Conference on Antimicrobial Agents and ChemotherapyBoston, MASeptember 12-15, 2010
- LawsonGHMcPhersonEAMurphyJRThe presence of precipitating antibodies in the sera of horses with chronic obstructive pulmonary disease (COPD)Equine Vet J197911172176114387
- ChudwinDSWaraDWCowanMJAmmannAJAspergillus pneumonia in chronic granulomatous disease: recurrence and long-term outcomeActa Paediatr Scand1982719159177158331
- TankanowLEichenhornMSDisseminated strongyloides stercoralis and Aspergillus fumigatus presenting as diffuse interstitial pneumonitis in a steroid-dependent chronic obstructive pulmonary disease patientHenry Ford Hosp Med J19883641433397296
- ThommiGBellGLiuJNugentKSpectrum of invasive pulmonary aspergillosis in immunocompetent patients with chronic obstructive pulmonary diseaseSouth Med J1991848288312068622
- KimmerlingEAFedrickJATenholderMFInvasive Aspergillus niger with fatal pulmonary oxalosis in chronic obstructive pulmonary diseaseChest19921018708721541168
- BulpaPADiveAMGarrinoMGChronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?Intensive Care Med200127596711280674
- ValleJMGonzález-BarcalaFJAlvarez-DobaňoJMValdésLInvasive pulmonary aspergillosis in chronic obstructive pulmonary diseaseRev Med Chil2010138612620 Spanish20668818
- LucenaPBarberánJErolesGSignificance of lower respiratory tract cultures yielding Aspergillus spp. Growth in a hospital without transplant patientsRev Esp Quimioter201023190195 Spanish21191557
- PittetDHugueninTDharanSUnusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19961545415448756836
- AliZAAliAATempestMEWiselkaMJInvasive pulmonary aspergillosis complicating chronic obstructive pulmonary disease in an immunocompetent patientJ Postgrad Med200349788012865577
- WiestPMFlaniganTSalataRAShlaesDMKatzmanMLedermanMMSerious infectious complications of corticosteroid therapy for COPDChest198995118011842721249
- ConesaDRelloJVallésJMariscalDFerreresJCInvasive aspergillosis: a life-threatening complication of short-term steroid treatmentAnn Pharmacother199529123512378672828
- Carrascosa-PorrasMHerreras-MartinezRCorral-MonesJAresMZabaleta-MurquiondoMRüchelRFatal Aspergillus myocarditis following short-term corticosteroid therapy for chronic obstructive pulmonary diseaseScand J Infect Dis20023422422712035764
- AderFInvasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal diseaseCurr Infect Dis Rep20101240941621308548
- PatelDAGaoXStephensJMForshagMSTaralloMUS hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional hostJ Med Econ20111422723721385144
- Von EiffMRoosNSchltenRHesseMZuhlsdorfMLoo van deJPulmonary aspergillosis: early diagnosis improves survivalRespiration1995623413478552866
- CaillotDCasasnovasOBernardAImproved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgeryJ Clin Oncol1997151391478996135
- Ostrosky-ZeichnerLInvasive mycoses: diagnostic challengesAm J Med2012125Suppl 1S14S2422196205
- MeerssemanWLagrouKMaertensJGalactomannan in bronchoalveolar lavage fluid. A tool for diagnosing aspergillosis in intensive care unit patientsAm J Respir Crit Care Med2008177273417885264
- ReinwaldMSpiessBHeinzWJDiagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samplesEur J Haematol20128912012722650156
- MaertensJMaertensVTheunissenKBronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseasesClin Infect Dis2009491688169319886801
- HsuL-YDingYPhuaJGalactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patientsBMC Infect Dis201010444920199673
- HeHDingLChangSLiFZhanQValue of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary diseaseMed Mycol20114934535120936913